IL10 and neoplasm: Elevated numbers of regulatory T (TREG) cells, Myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and the presence of inhibitory cytokines such as transforming growth factor-β (TGF-β) and interleukin 10 (IL-10) collectively suppress T cell activation and persistence [65,66,67].